Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON51484
NL-OMON51484
Recruiting
Not Applicable

Biomarker identification of radionuclide therapy-induced radiation responses. - Radio-Marker

Moleculaire genetica0 sites25 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsNeuroendocrine tumor1002911210014713

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neuroendocrine tumor
Sponsor
Moleculaire genetica
Enrollment
25
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Moleculaire genetica

Eligibility Criteria

Inclusion Criteria

  • •\- Patient with an advanced of metastatic, well\-differentiated
  • •gastroenteropancreatic neuroendocrine tumor .
  • •\- Indication for treatment with PRRT with 7\.4 GBq 177Lu\-DOTATATE by the
  • •multidisciplinary team.
  • •\- Age \>\= 18 years.

Exclusion Criteria

  • •\- Failure to obtain informed concent.
  • •\- Patient received ionizing radiation for imaging purposes within one week
  • •prior to PRRT or ionizing radiation for therapeutic purposes within 3 months
  • •prior to PRRT.
  • •\- Previous treatment with PRRT.
  • •\- Indication to receive a lower activity of PRRT than 7\.4 GBq.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Unknown
Not Applicable
Pathological biomarker search for the radiotherapy convalescence prediction factor of the esophageal cancer by the highly sensitive fluorescence immunostainingEsophageal cancer
JPRN-UMIN000025542Tohoku University90
Recruiting
Not Applicable
Biomarker associated with the radiation therapy of renal cell cancer.C64Malignant neoplasm of kidney, except renal pelvis
DRKS00010924niversitätsklinikum Freiburg, Klinik für Strahlenheilkunde10
Suspended
Not Applicable
Radiobiological characterisation and therapy monitoring of oligo- compared to polymetastatic breast cancerC50Malignant neoplasm of breast
DRKS00031591Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Hamburg-Eppendorf50
Unknown
Not Applicable
Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid TumorsRadiation ToxicityAdvanced CancerRadiosensitivity
NCT04110223Shandong Cancer Hospital and Institute600
Recruiting
Not Applicable
Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STSSoft Tissue Sarcomas
NCT05739084Centre Leon Berard300